May 23, 2019 – Currently available evidence does not support the recent "Hour-1 Bundle" recommendation to perform five initial treatment steps within the first hour in patients with sepsis. That's the position of the European Society of Emergency Medicine (EUSEM), published in the May/June issue of the European Journal of Emergency Medicine, official journal of EUSEM. The journal is published in the Lippincott portfolio by Wolters Kluwer.
While acknowledging the importance of early recognition and treatment of sepsis, "The EUSEM wishes to express its concerns regarding the low level of evidence that underlies these guidances, and potential implication from an emergency physician point of view," according to the position paper by a panel of leading European emergency medicine specialists. The lead author is Prof. Yonathan Freund of Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris.
Concerns About 'Unexpected Harm' from Updated Sepsis Recommendations
In 2018, the Surviving Sepsis Campaign (SSC) issued an updated set of recommendations for initial treatment of sepsis and septic shock. The SSC is a global cooperative effort to improve treatment and reduce the risk of death from sepsis. Sepsis is a common and potentially life-threatening condition, occurring when the immune system mounts an overwhelming inflammatory response to infection.
The 2018 update introduced an "Hour-1 Bundle" of steps that healthcare professionals should begin as soon as time of triage: measuring blood lactate level, performing blood cultures, and starting treatment with antibiotics, intravenous fluids, and vasopressors if indicated.
The recommendation to perform these five steps within the first hour represents an acceleration of treatment, compared to the 3-hour target recommended in the 2016 SSC guidelines. Even the definition of "time zero" moved forward: from the time of sepsis recognition to the time of triage in the emergency department.
The new EUSEM position paper is an "expression of concern" over the updated recommendations. Noting the prominent role of emergency physicians in initial recognition and care of patients with sepsis, the EUSEM position paper highlights the low to moderate quality of evidence supporting the Hour-1 Bundle. "[T]he empirical basis for the reduced timeframe of the sepsis bundle is too weak to be mandatory," Prof. Freund and coauthors write.
The authors note deficiencies in other recommendations as well, raising questions about the benefits of early lactate measurement and intravenous fluids. Rather, they conclude, starting antibiotics as soon as the likely diagnosis of sepsis is made seems to be the key factor responsible for the improvement in outcomes with early treatment.
The EUSEM statement questions whether it is practical to start all elements of the sepsis bundle within the first hour – especially since up to one in five patients initially diagnosed with sepsis are ultimately found to have a noninfectious diagnosis. Prof. Freund and colleagues also express concern about possible unintended consequences of setting the "Hour-1 Bundle" as the standard of care. They write, "In emergency medicine, unrealistic time targets taken as quality indicators may cause unexpected harm."
"[C]ompletion of the sepsis bundle within one hour after triage is not evidence based and may even be potentially harmful," Prof. Freund and coauthors conclude. "Therefore, EUSEM cannot support the new SSC guidance, but emphasizes the early recognition of sepsis and timely administration of antibiotics in appropriately selected patients within 1 hour of triage."
About the European Journal of Emergency Medicine
The European Journal of Emergency Medicine is the official journal of the European Society for Emergency Medicine. It is devoted devoted to serving the European emergency medicine community and to promoting European standards of training, diagnosis and care in this rapidly growing field. Published bimonthly, the Journal offers original papers on all aspects of acute injury and sudden illness. With a multidisciplinary approach, the European Journal of Emergency Medicine publishes scientific research, topical reviews, news of meetings and events of interest to the emergency medicine community.
About the European Society for Emergency Medicine
The European Society for Emergency Medicine (EUSEM) is a non-profit making scientific organization with an aim to promote and foster the concept, the philosophy and the art of Emergency Medicine throughout Europe. The main objective of EUSEM is to help and support European countries to implement the specialty of Emergency Medicine. Born as a society of individuals in 1994 from a multidisciplinary group of experts in Emergency Medicine, since 2005 EUSEM also incorporates national society members. There are currently 36 European national societies of Emergency Medicine.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information, software solutions, and services for the health, tax & accounting, finance, risk & compliance, and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer, headquartered in the Netherlands, reported 2017 annual revenues of €4.4 billion. The company serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide.
Wolters Kluwer Health is a leading global provider of trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.